ALLO
Price
$2.07
Change
-$0.00 (-0.00%)
Updated
Dec 18, 10:40 AM (EDT)
70 days until earnings call
ETNB
Price
$7.93
Change
-$0.05 (-0.63%)
Updated
Dec 18, 12:07 PM (EDT)
91 days until earnings call
Ad is loading...

ALLO vs ETNB

Header iconALLO vs ETNB Comparison
Open Charts ALLO vs ETNBBanner chart's image
Allogene Therapeutics
Price$2.07
Change-$0.00 (-0.00%)
Volume$5.96K
CapitalizationN/A
89bio
Price$7.93
Change-$0.05 (-0.63%)
Volume$404
CapitalizationN/A
ALLO vs ETNB Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. ETNB commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and ETNB is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ALLO: $2.07 vs. ETNB: $7.98)
Brand notoriety: ALLO and ETNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 92% vs. ETNB: 123%
Market capitalization -- ALLO: $434.02M vs. ETNB: $938.31M
ALLO [@Biotechnology] is valued at $434.02M. ETNB’s [@Biotechnology] market capitalization is $938.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileETNB’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • ETNB’s FA Score: 0 green, 5 red.
According to our system of comparison, ETNB is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while ETNB’s TA Score has 2 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 5 bearish.
  • ETNB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than ETNB.

Price Growth

ALLO (@Biotechnology) experienced а -5.48% price change this week, while ETNB (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.84%. For the same industry, the average monthly price growth was +1.08%, and the average quarterly price growth was +4.66%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

ETNB is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-4.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($938M) has a higher market cap than ALLO($434M). ETNB YTD gains are higher at: -28.559 vs. ALLO (-35.514).
ALLOETNBALLO / ETNB
Capitalization434M938M46%
EBITDAN/AN/A-
Gain YTD-35.514-28.559124%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOETNB
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 7 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+0.49%
FATE - ALLO
58%
Loosely correlated
-6.00%
NTLA - ALLO
57%
Loosely correlated
-1.87%
CRSP - ALLO
56%
Loosely correlated
+0.88%
CRBU - ALLO
55%
Loosely correlated
+1.57%
PRME - ALLO
54%
Loosely correlated
-3.00%
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+1.01%
AKRO - ETNB
63%
Loosely correlated
+4.72%
PLRX - ETNB
49%
Loosely correlated
+4.74%
NTLA - ETNB
46%
Loosely correlated
-1.87%
IDYA - ETNB
46%
Loosely correlated
+1.07%
ALLO - ETNB
45%
Loosely correlated
+0.49%
More